ICL Group heads into the second week of June with its sharpest monthly price slide in recent months, yet the short-selling community is quietly reducing exposure — a divergence that makes the setup genuinely interesting.
The stock closed at $5.59 on June 9, down roughly 10% on the week and 12% over the past month. The decline is broad-based rather than event-driven — no single catalyst in the data explains the move. What makes it unusual is that shorts are not piling in. Short interest fell 8.5% in a single session on June 9, and is down 10% on the week, trimming the position to around 3.3 million shares. That is the lowest reading in the 30-day history and represents a meaningful reversal from the late-May peak of just over 4 million shares. The lending market tells the same story: borrow availability has expanded sharply, now running at 671% — meaning there are more than six shares available to borrow for every one currently lent out. That is well above the 52-week tightest reading of 265% recorded in mid-May, and the borrow cost of 6.8% has dropped back from a spike above 11% on June 3. The positioning picture is one of short sellers unwinding, not building.
Options offer no obvious counterweight to that read. The put/call ratio is running at 0.038, almost exactly in line with its 20-day average of 0.035 and comfortably below its 52-week high of 0.39. There is no unusual demand for downside protection. The ORTEX short score has also softened steadily — from 39.2 on June 2 to 34.4 on June 9 — a seven-day decline that reflects fewer bearish signals, not more. Together, the positioning data reads as cautious unwinding rather than a new bear thesis being established.
The fundamental case for ICL remains mixed. EPS momentum is genuinely strong — the 30-day momentum factor scores in the 84th percentile, and forward EPS growth ranks in the 77th. The dividend score is high at 85. Yet on price, the market is assigning the stock just 12.9x trailing earnings and 5.8x EV/EBITDA — both multiples have compressed over the past 30 days. The PE multiple has shed 3.3 points in the last month alone, tracking the price lower without any improvement in earnings expectations to cushion it. The sector score sits at a neutral 50, and the broader fertilizer complex has been under pressure: close peer ASPN fell 11.3% on the week, and the TASE-listed parent vehicle ILCO dropped 8.8%. ICL's recent Q1 result did produce a 3% one-day gain on May 13, but the five-day follow-through was essentially flat at 0.9% — suggesting the market digested the beat quickly and moved on.
On ownership, the structure is stable but concentrated. Israel Corporation holds 43.9% of shares — an anchor that limits the float and explains why short interest as a proportion of free float is difficult to calculate cleanly. Among institutional movers, Vanguard Capital Management and BlackRock both added shares in Q1 2026, while Citadel initiated a fresh position of 1.5 million shares. These are modest additions in absolute terms but directionally positive against the backdrop of price weakness.
The next scheduled catalyst is the August 5 earnings date. Between now and then, the story worth watching is whether the short-covering pace continues as the stock trades near multi-month lows, or whether the price weakness eventually attracts fresh bearish positioning despite the currently loose borrow conditions.
See the live data behind this article on ORTEX.
Open ICL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
